An octadentate bis(semicarbazone) macrocycle: a potential chelator for lead and bismuth radiopharmaceuticals.
Bismuth
/ chemistry
Chelating Agents
/ chemistry
Coordination Complexes
/ chemistry
Crystallography, X-Ray
Cyclams
/ chemistry
Kinetics
Lead
/ chemistry
Magnetic Resonance Spectroscopy
Models, Molecular
Molecular Conformation
Radiopharmaceuticals
/ chemistry
Semicarbazones
/ chemistry
Structure-Activity Relationship
Journal
Dalton transactions (Cambridge, England : 2003)
ISSN: 1477-9234
Titre abrégé: Dalton Trans
Pays: England
ID NLM: 101176026
Informations de publication
Date de publication:
03 Nov 2020
03 Nov 2020
Historique:
pubmed:
21
10
2020
medline:
30
7
2021
entrez:
20
10
2020
Statut:
ppublish
Résumé
A variant of 1,4,7,10-tetraazacyclododecane (cyclen) bearing two semicarbazone pendant groups has been prepared. The octadentate ligand forms complexes with Bi3+ and Pb2+. X-ray crystallography showed that the neutral ligand provides an eight-coordinate environment for both metal ions and intermolecular hydrogen bond interactions have influenced the coordination environments of both complexes in the solid state. NMR spectroscopy revealed a fluxional environment for both complexes. The ligand was radiolabeled with the α-emitting radioactive isotope 213Bi3+, which is used in systemic targeted radiotherapy. The resulting complex was stable in serum for at least 90 min (two decay half-lives). The Pb2+ complex has reasonably fast kinetics of formation (t1/2 = 20 min) at 25 °C and pH 7.4. The Bi3+ and Pb2+ complexes show kinetic stability in 1.2 M HCl (half-lives of 214 min and 47 min, respectively). This is the first description of a macrocycle bearing semicarbazone pendant groups and its utility in coordinating main group metals, specifically those with radiotherapeutic potential.
Substances chimiques
Chelating Agents
0
Coordination Complexes
0
Cyclams
0
Radiopharmaceuticals
0
Semicarbazones
0
Lead
2P299V784P
cyclen
964584YO2O
Bismuth
U015TT5I8H
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM